DXS International plc (DXSP) Ordinary 0.33p
DXS International PLC is engaged in the development and distribution of clinical decision support to general practitioners, nurses and retail pharmacies in the United Kingdom and South Africa. The Company is also engaged in licensing its services to various clinical commissioning groups (CCGs); selling of e-detailing opportunities to the pharmaceutical industry and the United Kingdom care sector, and licensing of DXS technology to healthcare publishers. The Company's products include DXS Point-of-Care (DXS PoC), which is a clinical decision support system (CDSS); DXS Best Pathway, which supports the implementation of CCG designated clinical guidelines and protocols; DXS Best Script, which is a medicine database; DXS Best Triage, which manages CCG referral triaging requirements, and DXS Directory-of-Services (DoS), which provides general practitioners (GPs) and nurses with a directory of available referral services in the work flow.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.